Upfronts Back In Front
Streaming dollars are becoming a key part of upfront negotiations as the market bounces back after a tough 2020. Last year, uncertainty reigned. Sports were on pause and marketers wanted flexibility. But this year, the market is on the rebound and inventory is scarce. Marketers with older target audiences (think pharma) will continue to spend big on linear TV, but marketers whose products appeal to younger audiences will largely opt for streaming. It’s going to cost them, though. Longtime TV advertisers with grandfathered-in pricing discounts can’t get the same discounted rates for streaming ads, according to buyers interviewed by The Wall Street Journal.
Healey sues Publicis Health for allegedly âdeceptiveâ advertising tactics that fueled stateâs opioid crisis
By Caroline Enos Globe Correspondent,Updated May 8, 2021, 2 hours ago
Email to a Friend
Bottles of Purdue Pharma L.P. OxyContin medication.George Frey/Bloomberg
Attorney General Maura Healey is suing the marketing firm Publicis Health for fueling Massachusettsâ opioid crisis through allegedly âunfair and deceptiveâ tactics to sell more OxyContin, her office announced.
A suit filed in Suffolk Superior Court on Thursday alleges that Publicis used these strategies under several trade names, including Rosetta and Razorfish Health, to persuade doctors to prescribe higher doses of opioids to more patients for longer stretches of time.
Massachusetts sues Publicis Health over ties to Purdue, opioids
The lawsuit claims the company is responsible for marketing strategies that aimed to reduce hesitancy among prescribers to give patients OxyContin.
by Lecia Bushak
(Credit: Getty Images)
To continue reading this article you need to be registered with Campaign. Registration is free and only takes a minute. Register here or sign in below if you already have an account.
Sign in
Free email bulletins
Massachusetts sues Publicis Health over ties to Purdue, opioids
The lawsuit claims the company is responsible for marketing strategies that aimed to reduce hesitancy among prescribers to give patients OxyContin.
by Lecia Bushak, MM+M
(Photo credit: Getty Images).
Register
Limited Article Views (Excludes Subscriber Only Content)
Select Newsletters (Excludes Subscriber Only Bulletins)
Limited number of free email bulletins
Unlimited Access to PRWeek content
Daily Breakfast Briefing
PRWeek Daily News (subscriber-exclusive email bulletin)
Exclusive access to Power Book and Top 150 UK Consultancies/Agency Business Report content
PRWeek magazine delivered
US State Sues Publicis Subsidiary Over Role In Opioid Crisis
05/06/21 AT 11:27 PM
The state of Massachusetts sued a subsidiary of the French public relations firm Publicis on Thursday for its role promoting opioids in what became a major US health crisis.
That subsidiary, Publicis Health, is accused of helping Purdue Pharma urge doctors to prescribe its highly addictive painkiller OxyContin.
The lawsuit alleges that Publicis engaged in myriad unfair and deceptive strategies that influenced OxyContin prescribing across the nation, a statement by Massachusetts Attorney General Maura Healey s office said.
Those strategies were carried out through dozens of contracts between 2010 and 2019, worth more than $50 million, it stated.